Asimadoline hydrochloride

Synonyms: 阿西马朵林盐酸盐; EMD-61753 hydrochloride
Asimadoline (EMD-61753) hydrochloride 是一种口服有效、选择性、具有外周活性的 κ-opioid 激动剂,对豚鼠和人重组 κ-opioid 的 IC50 分别为 5.6 nM 和 1.2 nM,其血脑屏障渗透性低,具有外周抗炎作用,可改善糖尿病大鼠的异常性疼痛,并具有用于肠易激综合征 (IBS) 研究的潜力。
产品编号: MS-I85341 纯度: 99.57% CAS No.: 185951-07-9 分子式: C27H31ClN2O2 分子量: 451.00
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
3-5 天
100mg
询价
询价
500mg
询价
询价
1g
询价
询价
5g
询价
询价
(0.1 - 0.2mg)
询价
询价

产品描述

Asimadoline (EMD-61753) hydrochloride 是一种口服有效、选择性、具有外周活性的 κ-opioid 激动剂,对豚鼠和人重组 κ-opioid 的 IC50 分别为 5.6 nM 和 1.2 nM,其血脑屏障渗透性低,具有外周抗炎作用,可改善糖尿病大鼠的异常性疼痛,并具有用于肠易激综合征 (IBS) 研究的潜力。

生物实验数据

生物活性 Asimadoline (EMD-61753) hydrochloride is an orally active, selective, peripherally acting κ-opioid agonist with IC50 values of 5.6 nM and 1.2 nM for guinea pig and human recombinant κ-opioid, respectively, and it exhibits low blood-brain barrier permeability, exerts peripheral anti-inflammatory effects, ameliorates allodynia in diabetic rats, and holds potential for research on irritable bowel syndrome (IBS).
IC50 & Target κ opioid (Guinea pig):5.6 nM (EC50), κ opioid (human recombinant):1.2 nM (EC50)
体外研究
(In Vitro)

Asimadoline (EMD-61753) hydrochloride has high selectively in κ: μ: δ opioid binding ratios of 1:501:498 in human recombinant receptors. The IC50 for Asimadoline hydrochloride binding to μ-opioid receptors is 3 μM and to δ-opioid receptors is 0.7 μM. The IC50 values for D1, D2, kainate, σ, PCP/NMDA, H1, α1, α2, M1/M2, glycine, 5HT1A, 5HT1C, 5HT1D, 5HT2, 5HT3, AMPA and kainate/AMPA receptors are all >10 μM.
Asimadoline hydrochloride has affinity to sodium and L type Ca2+ ion channels at IC50 concentrations 150 to 800 fold the IC50 for the κ receptors.
At high concentrations, Asimadoline hydrochloride demonstrates spasmolytic action against 400 μM barium chloride in the rat duodenum (IC50=4.2 μM), suggesting that Asimadoline hydrochloride may block the direct stimulant effects of barium on smooth muscle through mechanisms that are not identified.

体内研究
(In Vivo)

Asimadoline (EMD-61753 hydrochloride; 1, 5, 15 mg/kg; s.c.) acutely ameliorates both formalin-evoked hyperalgesia and tactile allodynia in diabetic rats.
The absorption rate following oral administration is 80% in rats and >90% in dogs and monkeys. The metabolism of Asimadoline hydrochloride is rapid and appears similar in animals and man. Asimadoline hydrochloride has peripheral anti-inflammatory actions that are partly mediated through increase in joint fluid substance P levels.
Treatment with Asimadoline hydrochloride (5 mg/kg/day; i.p.) produces marked (and sustained) attenuation of the disease with all three time regimes.

Animal Model: Adult female Sprague-Dawley rats
Dosage: 1, 5, 15 mg/kg
Administration: SC; single dose
Result: Acutely ameliorated both formalin-evoked hyperalgesia and tactile allodynia in diabetic rats.
性状 固体
颜色 Off-white to light yellow

化学信息

分子量 451.00
分子式 C27H31ClN2O2
CAS No. 185951-07-9
别名 阿西马朵林盐酸盐; EMD-61753 hydrochloride

储存&溶解度

体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (11.09 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式

4°C, sealed storage, away from moisture

*In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 240 mg/mL (532.15 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.2173 mL11.0865 mL22.1729 mL55.4324 mL
5 mM0.4435 mL2.2173 mL4.4346 mL11.0865 mL
10 mM0.2217 mL1.1086 mL2.2173 mL5.5432 mL
15 mM0.1478 mL0.7391 mL1.4782 mL3.6955 mL
20 mM0.1109 mL0.5543 mL1.1086 mL2.7716 mL
25 mM0.0887 mL0.4435 mL0.8869 mL2.2173 mL
30 mM0.0739 mL0.3695 mL0.7391 mL1.8477 mL
40 mM0.0554 mL0.2772 mL0.5543 mL1.3858 mL
50 mM0.0443 mL0.2217 mL0.4435 mL1.1086 mL
60 mM0.0370 mL0.1848 mL0.3695 mL0.9239 mL
80 mM0.0277 mL0.1386 mL0.2772 mL0.6929 mL
100 mM0.0222 mL0.1109 mL0.2217 mL0.5543 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础